The Role of Mesostriatal Dopamine System and Corticostriatal Glutamatergic Transmission in Chronic Pain

Overview

Journal Brain Sci

Publisher MDPI

Date 2021 Oct 23

PMID 34679376

Citations 13

Authors

Barbara Ziolkowska

Affiliations

Soon will be listed here.

Abstract

There is increasing recognition of the involvement of the nigrostriatal and mesolimbic dopamine systems in the modulation of chronic pain. The first part of the present article reviews the evidence indicating that dopamine exerts analgesic effects during persistent pain by stimulating the D2 receptors in the dorsal striatum and nucleus accumbens (NAc). Thereby, dopamine inhibits striatal output via the D2 receptor-expressing medium spiny neurons (D2-MSN). Dopaminergic neurotransmission in the mesostriatal pathways is hampered in chronic pain states and this alteration maintains and exacerbates pain. The second part of this article focuses on the glutamatergic inputs from the medial prefrontal cortex to the NAc, their activity changes in chronic pain, and their role in pain modulation. Finally, interactions between dopaminergic and glutamatergic inputs to the D2-MSN are considered in the context of persistent pain. Studies using novel techniques indicate that pain is regulated oppositely by two independent dopaminergic circuits linking separate parts of the ventral tegmental area and of the NAc, which also interact with distinct regions of the medial prefrontal cortex.

Citing Articles

Amitriptyline-perphenazine therapy for persistent idiopathic facial pain: translational perspectives from a retrospective study.

Marchesini M, Topi G, Bonezzi C, Demartini L J Anesth Analg Crit Care. 2024; 4(1):83.

PMID: 39695777 PMC: 11656548. DOI: 10.1186/s44158-024-00217-8.

Deciphering pain: molecular mechanisms and neurochemical pathways-challenges and future opportunities.

Dehghan B, Abolhasanzadeh N, Shademan B, Nourazarian A Front Mol Biosci. 2024; 11:1382555.

PMID: 39629040 PMC: 11613041. DOI: 10.3389/fmolb.2024.1382555.

Commentary: Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis.

Nagamine T Front Immunol. 2024; 15:1445334.

PMID: 39391309 PMC: 11464775. DOI: 10.3389/fimmu.2024.1445334.

Improving Sensitivity and Longevity of In Vivo Glutamate Sensors with Electrodeposited NanoPt.

Robbins E, Wong B, Pwint M, Salavatian S, Mahajan A, Cui X ACS Appl Mater Interfaces. 2024; 16(31):40570-40580.

PMID: 39078097 PMC: 11310907. DOI: 10.1021/acsami.4c06692.

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy.

Karsan N, Goadsby P CNS Drugs. 2024; 38(7):533-546.

PMID: 38822165 DOI: 10.1007/s40263-024-01091-2.

References

Watanabe M, Narita M, Hamada Y, Yamashita A, Tamura H, Ikegami D . Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer. Mol Pain. 2018; 14:1744806918756406. PMC: 5802605. DOI: 10.1177/1744806918756406. View

Lammel S, Lim B, Malenka R . Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology. 2013; 76 Pt B:351-9. PMC: 3778102. DOI: 10.1016/j.neuropharm.2013.03.019. View

Herz A, Shippenberg T . Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl). 1989; 98(2):203-6. DOI: 10.1007/BF00444692. View

Miley D, ABRAMS A, Atkinson J, Janowsky D . Successful treatment of thalamic pain with apomorphine. Am J Psychiatry. 1978; 135(10):1230-2. DOI: 10.1176/ajp.135.10.1230. View

Anagnostakis Y, Zis V, Spyraki C . Analgesia induced by morphine injected into the pallidum. Behav Brain Res. 1992; 48(2):135-43. DOI: 10.1016/s0166-4328(05)80149-4. View

Gerfen C, Engber T, Mahan L, Susel Z, Chase T, Monsma Jr F . D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990; 250(4986):1429-32. DOI: 10.1126/science.2147780. View

Albin R, Young A, Penney J . The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989; 12(10):366-75. DOI: 10.1016/0166-2236(89)90074-x. View

Spanagel R, Herz A, Shippenberg T . Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A. 1992; 89(6):2046-50. PMC: 48593. DOI: 10.1073/pnas.89.6.2046. View

Meda K, Patel T, Braz J, Malik R, Turner M, Seifikar H . Microcircuit Mechanisms through which Mediodorsal Thalamic Input to Anterior Cingulate Cortex Exacerbates Pain-Related Aversion. Neuron. 2019; 102(5):944-959.e3. PMC: 6554049. DOI: 10.1016/j.neuron.2019.03.042. View

10.

Ford B . Pain in Parkinson's disease. Mov Disord. 2010; 25 Suppl 1:S98-103. DOI: 10.1002/mds.22716. View

11.

Valek L, Auburger G, Tegeder I . Sensory neuropathy and nociception in rodent models of Parkinson's disease. Dis Model Mech. 2019; 12(6). PMC: 6602317. DOI: 10.1242/dmm.039396. View

12.

Gu L, Uhelski M, Anand S, Romero-Ortega M, Kim Y, Fuchs P . Pain inhibition by optogenetic activation of specific anterior cingulate cortical neurons. PLoS One. 2015; 10(2):e0117746. PMC: 4340873. DOI: 10.1371/journal.pone.0117746. View

13.

Gerfen C, Surmeier D . Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 2011; 34:441-66. PMC: 3487690. DOI: 10.1146/annurev-neuro-061010-113641. View

14.

Massaly N, Copits B, Wilson-Poe A, Hipolito L, Markovic T, Yoon H . Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System. Neuron. 2019; 102(3):564-573.e6. PMC: 6509001. DOI: 10.1016/j.neuron.2019.02.029. View

15.

Baliki M, Petre B, Torbey S, Herrmann K, Huang L, Schnitzer T . Corticostriatal functional connectivity predicts transition to chronic back pain. Nat Neurosci. 2012; 15(8):1117-9. PMC: 3411898. DOI: 10.1038/nn.3153. View

16.

Zhou L, Furuta T, Kaneko T . Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle. Neuroscience. 2003; 120(3):783-98. DOI: 10.1016/s0306-4522(03)00326-9. View

17.

Ozaki S, Narita M, Narita M, Iino M, Sugita J, Matsumura Y . Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area. J Neurochem. 2002; 82(5):1192-8. DOI: 10.1046/j.1471-4159.2002.01071.x. View

18.

Lee M, Manders T, Eberle S, Su C, Damour J, Yang R . Activation of corticostriatal circuitry relieves chronic neuropathic pain. J Neurosci. 2015; 35(13):5247-59. PMC: 4380998. DOI: 10.1523/JNEUROSCI.3494-14.2015. View

19.

Morgan M, Franklin K . 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 1990; 519(1-2):144-9. DOI: 10.1016/0006-8993(90)90072-j. View

20.

Suzuki T, Kishimoto Y, Misawa M, Nagase H, Takeda F . Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain. Life Sci. 1999; 64(1):PL1-7. DOI: 10.1016/s0024-3205(98)00537-2. View